FANCL Polyclonal Antibody

The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group L. Alternative splicing results in two transcript variants encoding different isoforms.

Introducing the FANCL Polyclonal Antibody, a cutting-edge scientific innovation meticulously developed to cater to the diverse needs of the biomedical research community. This exceptional product is designed to facilitate accurate and reliable detection of FANCL protein expression in various biological samples.

Crafted with utmost precision and utilizing state-of-the-art technology, the FANCL Polyclonal Antibody exhibits unparalleled specificity and sensitivity. Its unique composition ensures minimal cross-reactivity, enabling researchers to confidently explore the intricate mechanisms associated with FANCL protein.

The FANCL Polyclonal Antibody is meticulously validated through rigorous quality control measures, guaranteeing consistent and reproducible results. Its exceptional performance is further enhanced by its compatibility with a wide range of experimental techniques, including Western blotting, immunohistochemistry, and immunofluorescence.

This remarkable antibody is packaged in a convenient and user-friendly format, ensuring ease of use and storage. With a long shelf life and exceptional stability, the FANCL Polyclonal Antibody offers researchers the flexibility and reliability they require for their demanding research endeavors.

In summary, the FANCL Polyclonal Antibody represents a breakthrough in the field of biomedical research, providing researchers with an indispensable tool to unravel the complexities of FANCL protein expression. With its exceptional specificity, sensitivity, and compatibility, this product is poised to revolutionize the scientific community's understanding of FANCL protein and its associated biological processes.